DL
BIIB icon

Delta Lloyd’s Biogen BIIB Stock Holding History

Delta Lloyd’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$6.38M Buy
23,503
+1,815
+8% +$480K 0.18% 134
2017
Q1 		$5.93M Sell
21,688
-337
-2% -$95.3K 0.18% 136
2016
Q4 		$6.25M Buy
22,025
+4,651
+27% +$1.38M 0.2% 136
2016
Q3 		$5.44M Buy
17,374
+1,501
+9% +$445K 0.17% 115
2016
Q2 		$3.84M Sell
15,873
-1,076
-6% -$284K 0.13% 131
2016
Q1 		$4.41M Sell
16,949
-1,901
-10% -$502K 0.15% 125
2015
Q4 		$5.78M Buy
18,850
+1,150
+6% +$330K 0.2% 93
2015
Q3 		$5.17M Buy
17,700
+1,427
+9% +$471K 0.17% 124
2015
Q2 		$6.57M Buy
16,273
+6,064
+59% +$2.43M 0.2% 109
2015
Q1 		$4.31M Sell
10,209
-579
-5% -$228K 0.13% 113
2014
Q4 		$3.66M Buy
10,788
+719
+7% +$233K 0.11% 127
2014
Q3 		$3.33M Buy
10,069
+559
+6% +$184K 0.03% 129
2014
Q2 		$3M Buy
9,510
+1,162
+14% +$350K 0.09% 129
2014
Q1 		$2.55M Buy
8,348
+661
+9% +$210K 0.09% 127
2013
Q4 		$2.15M Sell
7,687
-27,483
-78% -$7.11M 0.08% 148
2013
Q3 		$8.47M Sell
35,170
-8,321
-19% -$1.86M 0.33% 65
2013
Q2 		$9.36M Buy
+43,491
New +$9.29M 0.36% 57

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Delta Lloyd's BIIB Position: Q2 2017 in Review

Delta Lloyd increased its Biogen (BIIB) stake by 8.4% in Q2 2017, buying an estimated $480K and bringing the position to 23,503 shares worth $6.38M. The position accounts for 0.18% of the portfolio, ranked #134.

Delta Lloyd first reported a position in BIIB in Q2 2013 and has held it in 17 quarters since. The position peaked at $9.36M in Q2 2013. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Delta Lloyd held 23,503 shares of Biogen worth $6.38M as of Q2 2017.
  • Delta Lloyd bought 1,815 Biogen shares in Q2 2017, an estimated $480K.
  • Biogen made up 0.18% of Delta Lloyd's portfolio in Q2 2017, its #134 holding.
  • Delta Lloyd first reported a position in Biogen in Q2 2013 and has held it in 17 quarters since.
  • Delta Lloyd's Biogen position peaked at $9.36M in Q2 2013.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.